Mirova Portfolio holdings
Mirova is a Paris-based asset manager devoted to sustainable investing and an affiliate of Natixis Investment Managers. Philippe Zaouati founded it in 2012 as a department of Natixis Asset Management (later renamed Ostrum Asset Management), and in 2014 it became a direct affiliate of Natixis Investment Managers. Mirova aims to build every portfolio to fit a climate path below 2°C, and its Althelia funds invest in the sustainable management of land and marine resources. It bought SunFunder, a Nairobi-based specialist in clean energy and climate investment in emerging markets, in 2022, and in 2020 became a mission-driven company under French law.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$6.29M |
| 2 |
Procter & Gamble
PG
|
+$5.09M |
| 3 |
NextEra Energy
NEE
|
+$3.11M |
| 4 |
Palo Alto Networks
PANW
|
+$3.04M |
| 5 |
Verizon
VZ
|
+$2.94M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$28.2M |
| 2 |
Stericycle Inc
SRCL
|
+$2.5M |
| 3 |
American Tower
AMT
|
+$2.35M |
| 4 |
Adobe
ADBE
|
+$2.03M |
| 5 |
American Water Works
AWK
|
+$1.95M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Healthcare | 26.54% |
| 3 | Industrials | 11.89% |
| 4 | Materials | 9.03% |
| 5 | Consumer Discretionary | 6.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Thermo Fisher Scientific
TMO
$259B
| $91.7M | 16.75% |
165,792
-49,229
| -23% | -$28.2M |
2018 Q4
22 quarters
|
|
|
2
Accenture
ACN
$148B
| $43M | 7.86% |
141,780
+20,533
| +17% | +$6.29M |
2023 Q1
5 quarters
|
|
3
Ecolab
ECL
$86.7B
| $37.4M | 6.83% |
157,158
-7,874
| -5% | -$1.82M |
2018 Q4
22 quarters
|
|
4
NVIDIA
NVDA
$3.93T
| $31.8M | 5.82% |
257,800
-15,460
| -6% | -$1.56M |
2018 Q4
22 quarters
|
|
5
Microsoft
MSFT
$3.89T
| $24.2M | 4.43% |
54,236
-155
| -0.3% | -$65.5K |
2018 Q4
22 quarters
|
|
6
Eli Lilly
LLY
$1.29T
| $23.2M | 4.25% |
25,662
-1,770
| -6% | -$1.42M |
2018 Q4
22 quarters
|
|
7
Waste Management
WM
$97B
| $13.7M | 2.51% |
64,421
+596
| +0.9% | +$124K |
2019 Q1
21 quarters
|
|
8
Visa
V
$794B
| $12.1M | 2.22% |
46,280
+4,494
| +11% | +$1.23M |
2018 Q4
22 quarters
|
|
|
9
Procter & Gamble
PG
$394B
| $12M | 2.19% |
72,564
+31,105
| +75% | +$5.09M |
2018 Q4
22 quarters
|
|
10
American Express
AXP
$215B
| $9.7M | 1.78% |
41,957
+960
| +2% | +$222K |
2021 Q1
13 quarters
|
|
11
Colgate-Palmolive
CL
$79.2B
| $9.5M | 1.74% |
98,346
+3,118
| +3% | +$288K |
2019 Q1
21 quarters
|
|
12
Stryker
SYK
$118B
| $9M | 1.64% |
26,455
| – | – |
2019 Q1
21 quarters
|
|
|
13
American Water Works
AWK
$29.8B
| $8.15M | 1.49% |
63,067
-15,430
| -20% | -$1.95M |
2018 Q4
22 quarters
|
|
14
Trane Technologies
TT
$91.5B
| $7.9M | 1.44% |
24,020
-373
| -2% | -$119K |
2023 Q4
2 quarters
|
|
15
Bentley Systems
BSY
$13.4B
| $7.67M | 1.4% |
155,381
-2,929
| -2% | -$152K |
2022 Q3
7 quarters
|
|
16
Tetra Tech
TTEK
$9.8B
| $7.64M | 1.4% |
186,915
-30,610
| -14% | -$1.25M |
2022 Q2
8 quarters
|
|
17
Xylem
XYL
$21.6B
| $7.3M | 1.33% |
53,812
-1,089
| -2% | -$148K |
2019 Q2
20 quarters
|
|
18
General Motors
GM
$72.5B
| $7.09M | 1.3% |
152,634
-21,734
| -12% | -$981K |
2019 Q1
21 quarters
|
|
19
Intuitive Surgical
ISRG
$154B
| $6.19M | 1.13% |
13,923
| – | – |
2019 Q1
21 quarters
|
|
20
Sunrun
RUN
$2.09B
| $6.13M | 1.12% |
516,595
| – | – |
2019 Q4
18 quarters
|
|
21
Trimble
TRMB
$12.8B
| $6.01M | 1.1% |
107,519
+11,063
| +11% | +$639K |
2020 Q3
15 quarters
|
|
22
Union Pacific
UNP
$180B
| $5.88M | 1.07% |
25,997
| – | – |
2018 Q4
22 quarters
|
|
23
Mastercard
MA
$576B
| $5.36M | 0.98% |
12,152
+823
| +7% | +$375K |
2018 Q4
22 quarters
|
|
24
International Flavors & Fragrances
IFF
$20.3B
| $5.32M | 0.97% |
55,875
+3,056
| +6% | +$280K |
2018 Q4
22 quarters
|
|
25
First Solar
FSLR
$18.4B
| $5.15M | 0.94% |
22,823
-8,913
| -28% | -$1.94M |
2022 Q3
7 quarters
|
|
Similar funds
Mirova's Q2 2024 Portfolio in Review
As of Q2 2024, Mirova held 151 positions worth $547M, down 3.1% from $565M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Mirova's Q2 2024 filing shows 16 new, 33 increased, 29 reduced and 28 closed positions. Its largest new stake was Palo Alto Networks: 20,300 shares worth $3.44M. The largest sale was Thermo Fisher Scientific, an estimated $28.2M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.
- Mirova's largest Q2 2024 buy was Palo Alto Networks: 20,300 shares worth $3.44M.
- Mirova added most to Accenture in Q2 2024, an estimated $6.29M increase.
- Mirova's biggest Q2 2024 reduction was Thermo Fisher Scientific, cutting an estimated $28.2M.
- Mirova fully exited Stericycle Inc in Q2 2024, selling an estimated $2.5M.
- Mirova's ten largest holdings make up 55% of its $547M portfolio in Q2 2024.
- Mirova opened 16 new positions and closed 28 in Q2 2024.
- Mirova's portfolio value fell 3.1% quarter-over-quarter to $547M.
Based on Mirova's 13F filing for Q2 2024, filed 13 Aug 2024.